Congratulations to Ms. Yingying Liu of the Collings Stevens Chronic Leukemia Research Laboratory, Terry Fox Laboratory, for being awarded a prestigious Leukaemia UK International Scholarship.
Dr. Jessica McAlpine, surgeon-scientist, BC Cancer and Vancouver General Hospital and professor and Dr. Chew Wei Chair in Gynaecologic Oncology at UBC
Using artificial intelligence (AI) to spot patterns across thousands of cancer cell images, the researchers have pinpointed a distinct subset of endometrial cancer that puts patients at much greater risk of recurrence and death, but would otherwise go unrecognized by traditional pathology and molecular diagnostics.
Four out of five children diagnosed with cancer survive over the long term after treatment, but for 20 per cent of them, standard treatment is not enough. To improve outcomes for these kids, researchers at the Michael Cuccione Childhood Cancer Research Program at BC Children’s Hospital Research Institute (BCCHR) have been working for over a decade on the BC Pediatric Personalized OncoGenomics (PedsPOG) study, using genomics to identify treatments specific to an individual child’s cancer.
Congratulations to Dr. Zhenwei Ma of Gao Lab (Integrative Oncology) for receiving a Banting Postdoctoral Fellowship.
The award is tied to the project titled, "Hydrogel adhesive artificial mucosa: a paradigm-shifting platform for esophageal cancer treatment and management.”
The Banting Postdoctoral Fellowships program provides funding to the very best postdoctoral applicants, both nationally and internationally, who will positively contribute to the country's economic, social, and research-based growth.
A BC Cancer-authored paper in the Canadian Association Medical Journal (CAMJ) has concluded that, with increased HPV screening rates, cervical cancer can be eliminated in Canada by almost a decade earlier than the federal government target of 2040.
BC Cancer – Prince George celebrated a significant milestone in early 2024 with the opening of a new clinical trial called CIRCULATE-NORTH-AMERICA, or CRC10, which marked the first time a systemic therapy clinical trial has been offered in northern B.C. to people with cancer. Since opening CRC10 in January 2024, the team in Prince George has enrolled two patients in this study.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.